Literature DB >> 18504700

Pelvic pain, adnexal masses, and ultrasound.

James M Shwayder1.   

Abstract

Pelvic pain, acute or chronic, accounts for more than 10% of referrals to gynecologists. Pain accounts for more than 40% of gynecologic diagnostic laparoscopies. Predicting operative findings is critical in planning surgical interventions, as well as preoperative and postoperative medical therapy. Ultrasound is useful in preoperative evaluation and in predicting surgical findings. This section reviews the use of various ultrasound modalities in evaluating adnexal masses and associated pelvic pain. Morphologic assessment with two-dimensional (2-D) ultrasound is the foundation for adnexal evaluation. The ultrasound morphology of common ovarian and adnexal masses is reviewed. The application and reliability of Doppler assessment is also reviewed. New advances, such as three-dimensional (3-D) sonography, 3-D vascular assessment, and contrast imaging, augment diagnostic accuracy. These advances may find future application in the clinical evaluation of patients. This section reviews the application of 2-D morphology, Doppler analysis, 3-D morphology, rendering and vascular assessment, and the use of contrast agents in the ultrasound evaluation of patients with adnexal masses and pelvic pain.

Entities:  

Mesh:

Year:  2008        PMID: 18504700     DOI: 10.1055/s-2008-1076144

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  2 in total

1.  Can lab data be used to reduce abdominal computed tomography (CT) usage in young adults presenting to the emergency department with nontraumatic abdominal pain?

Authors:  Meir H Scheinfeld; Soham Mahadevia; Evan G Stein; Katherine Freeman; Alla M Rozenblit
Journal:  Emerg Radiol       Date:  2010-03-20

2.  Minilaparotomy a good option in specific cases: a case report of bilateral ovarian germ cell tumor.

Authors:  D Bolla; N Deseö; A Sturm; A Schöning; C Leimgruber
Journal:  Case Rep Obstet Gynecol       Date:  2012-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.